Blueprint Neurotherapeutics Network (BPN) for Small Molecules Q&A Webinar

The Blueprint Neurotherapeutics Network for Small Molecule (BPN-Small Molecule), which provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through phase I clinical testing, will hold a Q&A Webinar for potential applicants on Tuesday, November 8, 2022. Program Director Dr. Charles Cywin will provide an overview of the program and answer questions about the application process. 

Registration